Agilent Technologies Inc (A) Shares Sold by Gabelli Funds LLC
Gabelli Funds LLC trimmed its stake in shares of Agilent Technologies Inc (NYSE:A) by 32.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,700 shares of the medical research company’s stock after selling 7,500 shares during the quarter. Gabelli Funds LLC’s holdings in Agilent Technologies were worth $1,051,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Dupont Capital Management Corp bought a new position in Agilent Technologies during the third quarter worth $101,000. Front Row Advisors LLC bought a new stake in shares of Agilent Technologies in the fourth quarter valued at about $106,000. Steward Partners Investment Advisory LLC bought a new stake in shares of Agilent Technologies in the third quarter valued at about $213,000. Cannell Peter B & Co. Inc. bought a new stake in shares of Agilent Technologies in the third quarter valued at about $215,000. Finally, First Allied Advisory Services Inc. bought a new stake in shares of Agilent Technologies in the third quarter valued at about $225,000.
Agilent Technologies Inc (NYSE:A) opened at $69.70 on Thursday. The company has a market capitalization of $22,054.50, a PE ratio of 28.83, a P/E/G ratio of 2.06 and a beta of 1.28. Agilent Technologies Inc has a 52 week low of $50.56 and a 52 week high of $75.00. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.30 and a quick ratio of 2.85.
A number of equities research analysts have recently issued reports on A shares. Barclays reissued a “buy” rating and issued a $74.00 target price on shares of Agilent Technologies in a research report on Monday, January 8th. Robert W. Baird reissued a “buy” rating and issued a $70.00 target price on shares of Agilent Technologies in a research report on Friday, October 20th. Deutsche Bank set a $75.00 target price on shares of Agilent Technologies and gave the company a “buy” rating in a research report on Tuesday, November 21st. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 target price for the company in a research report on Tuesday, October 31st. Finally, Cowen reissued a “hold” rating and issued a $70.00 target price on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Six research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $69.25.
In other Agilent Technologies news, SVP Jacob Thaysen sold 22,583 shares of the business’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $70.41, for a total transaction of $1,590,069.03. Following the completion of the transaction, the senior vice president now owns 63,042 shares of the company’s stock, valued at $4,438,787.22. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Michael R. Mcmullen sold 21,850 shares of the business’s stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $75.00, for a total value of $1,638,750.00. Following the transaction, the chief executive officer now directly owns 324,687 shares of the company’s stock, valued at approximately $24,351,525. The disclosure for this sale can be found here. In the last ninety days, insiders sold 219,991 shares of company stock valued at $15,468,795.
WARNING: This report was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2018/02/15/agilent-technologies-inc-a-shares-sold-by-gabelli-funds-llc.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.